Financials

  • Market Capitalization 156.87 M
  • Employee 29
  • Founded 2015
  • CEO N/A
  • Website nrxpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG00JCWDN63
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.67
ratio cours/chiffre d'affaires
23.7

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
3776
ADCT
ADC Therapeutics SA Common Shares
1.23 USD-0.81%-10.22%+14.95%-61.68%156.45 M USD
3777
HUMA
Humacyte, Inc. - Common Stock
0.71 USD+2.90%-5.33%-33.64%-69.53%157.63 M USD
3792
LENZ
LENZ Therapeutics, Inc. - Common Stock
4.93 USD-5.74%-13.96%-25.19%-84.83%154.58 M USD
3793
ALEC
Alector, Inc. - Common Stock
1.47 USD+5.76%-23.44%0.00%-7.55%163.21 M USD

Nouvelles